Therefore, we put forward the hypothesis that single nucleotide polymorphisms (SNPs) located within genes encoding PD-1 and PD-L1 molecules as well as SNP-SNP interactions (between variations in genes encoding receptor and ligand) are associated with RCC risk and outcomes. The gene discussed is CD274; the disease is renal cell adenocarcinoma.